## **Core Concept**
Sickle cell anemia is a genetic disorder that affects hemoglobin synthesis. It is characterized by the production of abnormal hemoglobin, known as hemoglobin S (HbS), which leads to the sickling of red blood cells. The defect in sickle cell anemia is related to a specific globin chain of hemoglobin.

## **Why the Correct Answer is Right**
The correct answer, , refers to the beta chain of hemoglobin. In sickle cell anemia, there is a point mutation in the HBB gene that codes for the beta-globin subunit of hemoglobin. This mutation results in the substitution of glutamic acid with valine at position 6 of the beta-globin chain (Glu6Val), leading to the production of abnormal beta chains and, consequently, HbS. This abnormal hemoglobin causes red blood cells to assume a sickle shape under certain conditions.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option refers to the alpha chain of hemoglobin. While alpha-thalassemia and other alpha-globin chain disorders exist, sickle cell anemia is not caused by a defect in the alpha chain.
- **Option C:** - This option might refer to other chains or combinations not directly relevant to the primary defect in sickle cell anemia.
- **Option D:** - Similar to option C, this might refer to other less relevant or incorrect chains in the context of sickle cell anemia.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that sickle cell anemia is caused by a mutation in the beta-globin gene, leading to the production of abnormal hemoglobin S. This results in clinical manifestations such as vaso-occlusive crises, chronic hemolysis, and increased susceptibility to infections. A classic clinical correlation is the increased risk of certain infections, such as those caused by encapsulated organisms like Streptococcus pneumoniae, in patients with sickle cell disease.

## **Correct Answer:** . beta chain